The ARTERY FIRST Approach for Resection of Pancreatic Head Cancer
This is a prospective non-randomized trial with two study groups. The trial is designed to
show if the ARTERY FIRST approach reduces the rate of R1 resections in patients undergoing
surgery for cancer of the pancreatic head.
After the diagnosis of cancer of the pancreatic head by clinical, laboratory and imaging
evaluation patients who are scheduled for resection will be screened for inclusion into the
trial. Informed consent is obtained at least on the day before surgery and patients meeting
the eligibility criteria will be enrolled into the study.
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Rate of R1 resections
positive resection margins as described by the pathologists of the University of Heidelberg
up to 1.5 years
Germany: General, Visceral and Transplantation Surgery, University hospidal Heidelberg